Barclays’s Prenetics Global PRE Stock Holding History

Barclays’s Portfolio PRE Stock Details PRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-521	Closed	-$10.1K	–	5567
2026 Q1	$10.1K	Buy	+521	New	+$9.7K	﹤0.01%	4698

Other funds holding PRE

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TGM

Tenzing Global Management San Francisco, California $216M AUM 75.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Barclays's PRE Position: Q2 2026 in Review

Barclays sold out of Prenetics Global (PRE) in Q2 2026, closing a stake of 521 shares — an estimated $10.1K sold.

Barclays first reported a position in PRE in Q1 2026 and held it in 1 quarter. The position peaked at $10.1K in Q1 2026. 25 funds tracked by Wall St. Rank hold PRE as of Q2 2026.

Barclays reported no remaining Prenetics Global position as of Q2 2026 after selling out during the quarter.
Barclays sold 521 Prenetics Global shares in Q2 2026, an estimated $10.1K.
Barclays first reported a position in Prenetics Global in Q1 2026 and held it in 1 quarter.
Barclays's Prenetics Global position peaked at $10.1K in Q1 2026.
25 funds tracked by Wall St. Rank held Prenetics Global as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.